Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- Countries with COVID-19 pandemic-associated reductions in childhood immunization coverage have not yet recovered, according to research published in the Oct. 31 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Camille E. Jones, Ph.D., from the CDC in Atlanta, and colleagues present trends in World Health Organization and UNICEF routine vaccination coverage estimates across 194 WHO member countries through 2023.
The researchers found that global coverage with the first and third doses of diphtheria-tetanus-pertussis-containing vaccine (DTPcv; 89 and 84 percent, respectively) and with the first dose of measles-containing vaccine (83 percent) stagnated during 2022 to 2023 and remained lower than levels seen before the pandemic. Approximately half of the world's 14.5 million children who did not receive the first DTPcv dose were in 31 WHO member countries with fragile, conflict-affected and vulnerable (FCV) settings. Countries' overall protection against vaccine-preventable diseases has been improved by introduction of new and underutilized vaccines such as a second measles-containing vaccine dose in the African region.
"The COVID-19 pandemic-associated disruptions in health systems augmented existing gaps and introduced new gaps in immunization coverage worldwide," the authors write. "Progress toward recovery has been uneven across countries, with low-income countries, the African region, and FCV settings having the most urgent need for action."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-02 06:00
Read more
- Florida Hospitals Brace for Hurricane Milton's Arrival
- Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains Low
- PTC Therapeutics Announces FDA Acceptance of Translarna NDA Resubmission
- ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome
- Standing More During the Day Does Not Cut Cardiovascular Risk
- Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions